Absence of AKT1 mutations in glioblastoma.
<h4>Background</h4>Oncogenic activation of the PI3K signalling pathway plays a pivotal role in the development of glioblastoma multiforme (GBM). A central node in PI3K downstream signalling is controlled by the serine-threonine kinase AKT1. A somatic mutation affecting residue E17 of the...
Guardado en:
Autores principales: | Fonnet E Bleeker, Simona Lamba, Carlo Zanon, Angela A van Tilborg, Sieger Leenstra, Dirk Troost, Theo Hulsebos, W Peter Vandertop, Alberto Bardelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9852c5c98a3b47aa91e3f8d3b920641e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutational profile of GNAQQ209 in human tumors.
por: Simona Lamba, et al.
Publicado: (2009) -
Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas
por: M. Udugama, et al.
Publicado: (2021) -
Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma: involvement of AKT signaling
por: Parvaneh Mahinfar, et al.
Publicado: (2022) -
BRAF mutations may identify a clinically distinct subset of glioblastoma
por: Samantha N. McNulty, et al.
Publicado: (2021) -
Integrated Analysis of Mutations, miRNA and mRNA Expression in Glioblastoma
por: Wang S, et al.
Publicado: (2021)